estimated millions infected leishmania tens millions related trypanosomes perhaps half billion people live areas endemic parasites risk established antileishmania compounds completely efficacious adverse reactions documented similar problems occur drugs used trypanosomes purine analogs allopurinol allopurinol riboside hand toxic organisms relatively benign humans demonstrated success treatment parasitic infections tor atypical multi drug resistance factor elicits resistance toxic nucleoside well pentostam amphotericin b number structurally unrelated compounds specific aim proposal determine tor exerts effects accomplished determining fate adenosine permease leishmania express less tor wild type cells western northern blotting ribonuclease protection assays enable us determine tor affects activity reporter permease broad long term objectives manipulate tor sensitivity leishmania toxic nucleosides clinically proven antileishmania compounds may possible tor reduce purine transport capability starve parasite absolutely essential nutrient